✦ LIBER ✦

Optimization of 3-(1 H -Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

✍ Scribed by Henke, Brad R.; Aquino, Christopher J.; Birkemo, Larry S.; Croom, Dallas K.; Dougherty,, Robert W.; Ervin, Gregory N.; Grizzle, Mary K.; Hirst, Gavin C.; James, Michael K.; Johnson, Michael F.; Queen, Kennedy L.; Sherrill, Ronald G.; Sugg, Elizabeth E.; Suh, Edward M.; Szewczyk, Jerzy W.; Unwalla, Rayomand J.; Yingling, Jeff; Willson, Timothy M.

Book ID: 120042048
Publisher: American Chemical Society
Year: 1997
Tongue: English
Weight: 613 KB
Volume: 40
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm970265x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3-(1 H -Indazol-3-ylmethyl)-1,5-benzodia

3-(1 H -Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents

✍ Henke, Brad R.; Willson, Timothy M.; Sugg, Elizabeth E.; Croom, Dallas K.; Dough 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 138 KB

ChemInform Abstract: 3-(2-(N-Phenylaceta

ChemInform Abstract: 3-(2-(N-Phenylacetamide))-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists.

✍ T. M. WILLSON; B. R. HENKE; T. M. MOMTAHEN; P. L. MYERS; E. E. SUGG; R. J. UNWAL 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

Discovery of 1,5-Benzodiazepines with Pe

Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

✍ Aquino, Christopher J.; Armour, Duncan R.; Berman, Judd M.; Birkemo, Larry S.; C 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 230 KB

5-cyano-1-[3-(N-methylpyrrolidin-2R-ylme

5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist

✍ John E Macor; David H Blank; Kishor Desai; Carol B Fox; B Kenneth Koe; Lorraine 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Discovery of 1,5-Benzodiazepines with Pe

Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent

✍ Hirst, Gavin C.; Aquino, Christopher; Birkemo, Lawrence; Croom, Dallas K.; Dezub 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 243 KB

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4